![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie und Liang, Peng
(2022):
Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.
In: Frontiers in Genetics, Bd. 13, 899125
2021
Liu, Qing; Liu, Da-Wo; Zheng, Ming-Jun; Deng, Lu; Wang, Hui-Min; Jin, Shan; Liu, Juan-Juan; Hao, Ying-Ying; Zhu, Lian-Cheng und Lin, Bei
(2021):
Human epididymis protein 4 promotes P-glycoprotein-mediated chemoresistance in ovarian cancer cells through interactions with Annexin II.
In: Molecular Medicine Reports, Bd. 24, Nr. 1, 496
2020
Zheng, Mingjun; Hu, Yuexin; Gou, Rui; Liu, Ouxuan; Nie, Xin; Li, Xiao; Liu, Qing; Hao, Yingying; Liu, Juanjuan und Lin, Bei
(2020):
Identification of immune-enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma.
In: Journal of Cellular and Molecular Medicine, Bd. 24, Nr. 5: S. 2819-2831
2019
Hu, Yue-Xin; Zheng, Ming-Jun; Zhang, Wen-Chao; Li, Xiao; Gou, Rui; Nie, Xin; Liu, Qing; Hao, Ying-Ying; Liu, Juan-Juan und Lin, Bei
(2019):
Systematic profiling of alternative splicing signature reveals prognostic predictor for cervical cancer.
In: Journal of Translational Medicine, Bd. 17, Nr. 1, 379